Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis

References

• Alexander M, Burch JB, Steck SE, Chen CF, Hurley TG, Cavicchia P, Ray M, Shivappa N, Guess J, Zhang H, et al. 2015. Case-control study of the PERIOD3 clock gene length polymorphism and colorectal adenoma formation. Oncol Rep. 33:935–941.
   PubMed Web of Science ®Google Scholar
• Bass J, Takahashi JS. 2010. Circadian integration of metabolism and energetics. Science. 330:1349–1354.
   PubMed Web of Science ®Google Scholar
• Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, Hrushesky WJ, Ben-David Y. 2001. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol. 158:1793–1801.
   PubMed Web of Science ®Google Scholar
• Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Maitre A, Pajak TF, Poulsen MG, et al. 2006. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 368:843–854.
   PubMed Web of Science ®Google Scholar
• Cao Q, Gery S, Dashti A, Yin D, Zhou Y, Gu J, Koeffler HP. 2009. A role for the clock gene per1 in prostate cancer. Cancer Res. 69:7619–7625.
   PubMed Web of Science ®Google Scholar
• Cermakian N, Boivin DB. 2009. The regulation of central and peripheral circadian clocks in humans. Obes Rev. 10(Suppl 2):25–36.
   PubMedGoogle Scholar
• Chen R, Yang K, Zhao NB, Zhao D, Chen D, Zhao CR, Tang H. 2012. Abnormal expression of PER1 circadian-clock gene in oral squamous cell carcinoma. Onco Targets Ther. 5:403–407.
   PubMed Web of Science ®Google Scholar
• Chi C, He ZF, Liu Y, Lin XM, Sun CC. 2013. Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi. 35:129–131.
   PubMedGoogle Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917.
   PubMed Web of Science ®Google Scholar
• Fu L, Kettner NM. 2013. The circadian clock in cancer development and therapy. Prog Mol Biol Transl Sci. 119:221–282.
   PubMed Web of Science ®Google Scholar
• Fu XJ, Li HX, Yang K, Chen D, Tang H. 2016. The important tumor suppressor role of PER1 in regulating the cyclin-CDK-CKI network in SCC15 human oral squamous cell carcinoma cells. Onco Targets Ther. 9:2237–2245.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Freeman SD. 2014. Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for “prime time”? Blood. 124:3345–3355.
   PubMed Web of Science ®Google Scholar
• Guan J, Zhang Y, Li Q, Zhang Y, Li L, Chen M, Xiao N, Chen L. 2016. A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC). Oncotarget. 7:70185–70193.
   PubMedGoogle Scholar
• Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY. 2012. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol. 33:149–155.
   PubMed Web of Science ®Google Scholar
• Langmesser S, Tallone T, Bordon A, Rusconi S, Albrecht U. 2008. Interaction of circadian clock proteins PER2 and CRY with BMAL1 and CLOCK. BMC Mol Biol. 9:41.
   PubMed Web of Science ®Google Scholar
• Leemans CR, Braakhuis BJ, Brakenhoff RH. 2011. The molecular biology of head and neck cancer. Nat Rev Cancer. 11:9–22.
   PubMed Web of Science ®Google Scholar
• Magnone MC, Langmesser S, Bezdek AC, Tallone T, Rusconi S, Albrecht U. 2015. The Mammalian circadian clock gene per2 modulates cell death in response to oxidative stress. Front Neurol. 5:289.
   PubMed Web of Science ®Google Scholar
• Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P, Andriulli A, et al. 2011. Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int. 28:841–851.
   PubMed Web of Science ®Google Scholar
• Mohamed AMR, Schrapp K, Owonikoko TK. 2015. Concurrent chemoradiation using weekly versus three weekly Cisplatin in locally advanced squamous cell carcinoma of the head and neck (SCCHN): A comparative analysis. J Clin Oncol (Meeting Abstr). 33:Abstr 6055.
   Web of Science ®Google Scholar
• Panda S, Hogenesch JB, Kay SA. 2002. Circadian rhythms from flies to human. Nature. 417:329.
   PubMed Web of Science ®Google Scholar
• Rana S, Mahmood S. 2010. Circadian rhythm and its role in malignancy. J Circadian Rhythms. 8:3.
   PubMedGoogle Scholar
• Reddy AB, O’Neill JS. 2010. Healthy clocks, healthy body, healthy mind. Trends Cell Biol. 20:36–44.
   PubMed Web of Science ®Google Scholar
• Relles D, Sendecki J, Chipitsyna G, Hyslop T, Yeo CJ, Arafat HA. 2013. Circadian gene expression and clinicopathologic correlates in pancreatic cancer. J Gastrointestinal Surg. 17:443–450.
   PubMed Web of Science ®Google Scholar
• Sato F, Wu Y, Bhawal UK, Liu Y, Imaizumi T, Morohashi S, Kato Y, Kijima H. 2011. PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells. Eur J Cancer. 47:1747–1758.
   PubMed Web of Science ®Google Scholar
• Xiong H, Yang Y, Yang K, Zhao D, Tang H, Ran X. 2018. Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer. Int J Oncol. 52:279–287.
   PubMed Web of Science ®Google Scholar
• Yagita K, Yamanaka I, Emoto N, Kawakami K, Shimada S. 2010. Real-time monitoring of circadian clock oscillations in primary cultures of mammalian cells using Tol2 transposon-mediated gene transfer strategy. BMC Biotechnol. 10:3.
   PubMed Web of Science ®Google Scholar
• Ya-ping WANG, Lu-chun HUA, Han-kun HAO. 2009. Clock gene hPer2 expression and its clinical significance in human colorectal carcinoma. Chin J Exp Surg. 26:1034–1036.
   Google Scholar
• Yu C, Yang SL, Fang X, Jiang JX, Sun CY, Huang T. 2015. Hypoxia disrupts the expression levels of circadian rhythm genes in hepatocellular carcinoma. Mol Med Rep. 11:4002–4008.
   PubMed Web of Science ®Google Scholar
• Zhanfeng N, Yanhui L, Zhou F, Shaocai H, Guangxing L, Hechun X. 2015. Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo. Oncotarget. 6:9951–9958.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zeng ZL, Yang J, Jin Y, Qiu MZ, Hu XY, Han J, Liu KY, Liao JW, Xu RH, et al. 2014. Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer. Int J Clin Exp Pathol. 7:619–630.
   PubMed Web of Science ®Google Scholar
• Zhao N, Yang K, Yang G, Chen D, Tang H, Zhao D, Zhao C. 2013. Aberrant expression of clock gene period1 and its correlations with the growth, proliferation and metastasis of buccal squamous cell carcinoma. PLoS One. 8:e55894.
   PubMed Web of Science ®Google Scholar